Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and venlafaxine nanofiber scaffold for diabetic foot ulcer healing
IRCT20160711028878N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of doxycycline and venlafaxine in diabetic foot ulcer (DFU) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Ulcer size and Pain-free walking distance. Started Oct 2015; status: completed.
02
Drugs
doxycyclinevenlafaxine
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20160711028878N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160711028878N2.